Proceedings of the PSK Conference (대한약학회:학술대회논문집)
- 2003.10b
- /
- Pages.245.1-245.1
- /
- 2003
Pharmacokinetics of DA-8159, a new PDE5 inhibitor, after single and 1-week repeated oral administrations in mice
- Park, Kyung-Jin (Dong-A Pharmaceutical Co. LTD.) ;
- Ahn, Gook-Jun (Dong-A Pharmaceutical Co. LTD) ;
- Kim, Dong-Hwan (Dong-A Pharmaceutical Co. LTD) ;
- Shim, Hyun-Joo (Dong-A Pharmaceutical Co. LTD) ;
-
Ahn, Byung-Ok
(Dong-A Pharmaceutical Co. LTD) ;
- Kim, Soon-Hoe (Dong-A Pharmaceutical Co. LTD) ;
- Kim, Won-Bae (Dong-A Pharmaceutical Co. LTD.)
- Published : 2003.10.01
Abstract
DA-8159 is a new PDEV (Phosphodiesterase V) inhibitor, synthesized by Dong-A Pharm., as an oral agent to treat male erectile dysfunction. To make a selection of the dosage of oral administration in carcinogenic studies, we studied preliminarily the pharmacokinetics of DA-8159 after single (at the 1
Keywords